![Cheryl A. Madsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cheryl A. Madsen
Consigliere Generale presso VIRACTA THERAPEUTICS, INC.
Posizioni attive di Cheryl A. Madsen
Società | Posizione | Inizio | Fine |
---|---|---|---|
VIRACTA THERAPEUTICS, INC. | Consigliere Generale | - | - |
Storia della carriera di Cheryl A. Madsen
Precedenti posizioni note di Cheryl A. Madsen
Società | Posizione | Inizio | Fine |
---|---|---|---|
PELOTON THERAPEUTICS, INC. | Consigliere Generale | - | - |
Medivation, Inc. /Old/ | Corporate Officer/Principal | - | - |
CALITHERA BIOSCIENCES, INC. | Consigliere Generale | - | - |
Formazione di Cheryl A. Madsen
University of California, Santa Cruz | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
General Counsel | 3 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
VIRACTA THERAPEUTICS, INC. | Health Technology |
CALITHERA BIOSCIENCES, INC. | Health Technology |
Aziende private | 2 |
---|---|
Peloton Therapeutics, Inc.
![]() Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |
Medivation, Inc. /Old/ | Health Technology |
- Borsa valori
- Insiders
- Cheryl A. Madsen
- Esperienza